BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30172787)

  • 1. Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain.
    Li N; Han ZL; Xu B; Zhang MN; Zhang T; Shi XR; Zhao WD; Guo YY; Zhang QQ; Fang Q
    Eur J Pharmacol; 2018 Oct; 837():53-63. PubMed ID: 30172787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
    Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
    Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
    Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
    Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
    Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
    Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
    Zhang R; Xu B; Zhang Q; Chen D; Zhang M; Zhao G; Xu K; Xiao J; Zhu H; Niu J; Li N; Fang Q
    Eur J Pharmacol; 2020 Aug; 880():173169. PubMed ID: 32416184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
    Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
    J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
    Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
    Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
    Zhang T; Han Z; Shi X; Zhao W; Wang Z; Zhang R; Xu B; Zhang M; Zhang Q; Xiao J; Zhu H; Zheng T; Fang Q
    Bioorg Med Chem; 2019 Feb; 27(4):630-643. PubMed ID: 30626554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities.
    Wang ZL; Pan JX; Song JJ; Tang HH; Yu HP; Li XH; Li N; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
    J Med Chem; 2016 Nov; 59(22):10198-10208. PubMed ID: 27798836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB
    Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
    Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q; Jiang TN; Li N; Han ZL; Wang R
    Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist.
    Xu B; Guo Y; Zhang M; Zhang R; Chen D; Zhang Q; Xiao J; Xu K; Li N; Qiu Y; Zhu H; Niu J; Zhang X; Fang Q
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13848. PubMed ID: 32281198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects.
    Xu B; Zhang Q; Chen D; Zhang M; Zhang R; Zhao W; Qiu Y; Xu K; Xiao J; Niu J; Shi Y; Li N; Fang Q
    Anesth Analg; 2023 Feb; 136(2):373-386. PubMed ID: 36638515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia.
    Mudgal A; Kumar K; Mollereau C; Pasha S
    Chem Biol Drug Des; 2016 Jun; 87(6):885-94. PubMed ID: 26802437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice.
    Wang P; Zheng T; Zhang M; Xu B; Zhang R; Zhang T; Zhao W; Shi X; Zhang Q; Fang Q
    Brain Res Bull; 2018 May; 139():48-55. PubMed ID: 29425797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.